10578 Science Center Drive
San Diego, CA 92121
(858) 625 2424
5 Sylvan Way
Parsippany, NJ 07054
(973) 254 3560
Since joining Pacira in 2008, Jim Scibetta has been given increasing responsibility and oversight. In 2015, Mr. Scibetta was appointed President, responsible for overseeing the day-to-day operations and tactical execution of the Company’s Customer and Patient Solutions (CPS) group, comprised of its customer-facing resources, and overseeing the Company’s Science Center Campus activities, which includes commercial manufacturing, tech transfer and R&D. Mr. Scibetta served as Senior Vice President, Chief Financial Officer and Head of Technical Operations from 2008 through May 2016. Mr. Scibetta led the Company’s 2011 IPO and subsequent debt and equity financings as Chief Financial Officer.
Mr. Scibetta has more than 25 years of operational and financial executive and investment banking experience serving public and private healthcare and life sciences companies. Prior to joining Pacira, Mr. Scibetta served as CFO of Bioenvision Inc. (NASDAQ: BIVN), an international biotechnology company that developed and commercialized products for hematological and solid tumor cancers. In 2007, Mr. Scibetta was instrumental in completing the $345 million sale of Bioenvision to Genzyme Corporation (NASDAQ: GENZ). Mr. Scibetta consulted to Genzyme from the time of the sale in 2007 until he joined Pacira. From 2001 to 2006, Mr. Scibetta was Executive Vice President and CFO of Merrimack Pharmaceuticals Inc. Prior to 2001, Mr. Scibetta spent over a decade in investment banking where he was responsible for sourcing and executing transactions for a broad base of public and private healthcare and life sciences companies.
Mr. Scibetta currently serves as Chairman of the audit committee of Matinas BioPharma. Mr. Scibetta has prior Board experience with life sciences companies Nephros Inc., Merrimack Pharmaceuticals and Labopharm Inc.
Mr. Scibetta received his Bachelor of Science in Physics from Wake Forest University and an MBA from the University of Michigan. He also completed the Harvard Business School executive education program "Leadership & Strategy in Pharmaceuticals and Biotechnology." Mr. Scibetta was named the 2013 CFO of the Year by njbiz.com.